The UK's National Biologics Manufacturing Centre
CPI is the UK’s national technology and innovation centre for the process manufacturing industries. At the National Biologics Manufacturing Centre, CPI combines state of the art facilities and technical expertise to support the growth and development of the UK biologics industry and supply chain.
CPI has worked on the Nanofacturing project to develop manufacturing methods and improve supply chain co-ordination.
BioStreamline, which focuses on advancing novel therapies to deliver drugs faster and cheaper, will end in June 2019.